Carlumab (Anti-CCL2 / MCP1)

Ask supplier a question | View on supplier's website

Carlumab (Anti-CCL2 / MCP1) is a humanised monoclonal antibody targeting CCL2 with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2573
Sku #	A2573-1mg*5
Pricing	1mg*5, $970.00

Feedback